THIAZOLIDINEDIONES ACTIVATE THE GLUCOCORTICOID RECEPTOR
Tersigni M., Matthews L., Berry A., Ray D., Ianaro A. (Napoli, Manchester) |
SONIC HEDGEHOG (SHH) INDUCES PROLIFERATION OF NEURAL PROGENITOR CELLS ISOLATED FROM RAT POSTNATAL CEREBELLUM.
Barbierato M., Soffia S., Zusso M., Negro A., Skaper S., Trevisan L., Debetto P., Giusti P. (Padova) |
DEFICIENCY OF POLYCYSTIC KIDNEY DISEASE-1 GENE (PKD1) EXPRESSION INCREASES A3 ADENOSINE RECEPTORS IN HUMAN RENAL CELLS
Varani K., Aguiari G., Vincenzi F., Tosi A., Gessi S., Sacchetto V., Bogo M., Del Senno L., Borea P. (Ferrara) |
THERMODYNAMIC ANALYSIS IN DRUG-RECEPTOR BINDING: THE A3 ADENOSINE RECEPTOR
Vincenzi F., Varani K., Targa M., Tosi A., Gessi S., Merighi S., Borea P. (Ferrara) |
PHARMACOLOGICAL CHARACTERIZATION OF NOVEL ALLOSTERIC ENHANCERS OF THE A1 ADENOSINE RECEPTORS
Tosi A., Varani K., Romagnoli R., Vincenzi F., Targa M., Preti D., Baraldi P., Borea P. (Ferrara) |
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS
SIMIONI C., MERIGHI S., GESSI S., VARANI K., MIRANDOLA P., LEUNG E., MACLENNAN S., BARALDI P., BOREA P. (Ferrara, Parma, Cary) |
L163,255, A SYNTHETIC GROWTH HORMONE SECRETAGOGUE, ALTERS CA2+ HOMEOSTASIS AND MODULATES CELL VIABILITY OF SKELETAL MUSCLE
Gramegna G., Liantonio A., Giannuzzi V., Conte Camerino D. (Bari) |
PERINATAL HYPOXIA IN NEONATAL AND ADULT BRAIN: P2X7 ACTIVITY AND GLUTAMATE RELEASE
Barbieri R., Alloisio S., Cervetto C., Mazzotta M., Marcoli M., Maura G., Nobile M. (Genova) |
ACTIVATION OF MGLU2/3 METABOTROPIC GLUTAMATE RECEPTORS NEGATIVELY REGULATES THE STIMULATION OF INOSITOL PHOSPHOLIPID HYDROLYSIS MEDIATED BY 5-HT2A SEROTONIN RECEPTORS IN THE FRONTAL CORTEX OF LIVING MICE
Grohmann U., Volpi C., Orabona C., Vacca C., Bianchi R., Belladonna M., Puccetti P., Fioretti M., Fallarino F. (Perugia, Roma, Pozzilli IS) |
PRESYNAPTIC UROTENSIN RECEPTORS IN THE CERVICAL SPINAL MOTONEURONS: FACILITATION OF ACETYLCHOLINE RELEASE
Cervetto C., Mazzotta M., Bruzzone F., Diaspro A., Bianchini P., Vallarino M., Maura G., Leprince J., Vaudry H., Marcoli M. (Genova, Mont-Saint-Aignan) |
C-TERMINAL DOMAIN REQUIREMENT FOR P2X7 RECEPTOR TO FUNCTION AS A CHANNEL/PORE FOR GLUTAMATE
Mazzotta M., Cervetto C., Alloisio S., Nobile M., Maura G., Marcoli M. (Genova) |
SYNERGISTIC INHIBITION OF AGS GASTRIC CANCER CELL GROWTH BY COMBINED TREATMENT WITH SMALL MOLECULE RECEPTOR TYROSINE KINASE INHIBITORS AND/OR PROTEASOME INHIBITORS.
DAMIANO V., TROIANI T., PIEGARI E., RUSSO R., MORGILLO F., MARTINELLI E., CIARDIELLO F., ROSSI F., BERRINO L. (Napoli) |
CYTOPLASMIC FES TYROSINE KINASE IS A DOWN-STREAM EFFECTOR OF THE INSULIN-LIKE GROWTH FACTORS (IGFS)/IGF-I RECEPTOR (IGF-IR) SYSTEM OF NEUROBLASTOMA CELLS
Gnemmi I., Condorelli F., Canonico P. (Novara) |
IN NEUROBLASTOMA CELL LINES, CYTOPLASMIC FES TYROSINE KINASE LINKS THE INSULIN-LIKE GROWTH FACTOR-I RECEPTOR (IGF-IR) ACTIVATION TO STAT3-DEPENDENT ANTI-APOPTOTIC EFFECTS.
Sanzone S., Condorelli F., Canonico P. (Novara) |
CHARACTERIZATION OF THE ENZYME RESPONSIBLE FOR THE DEGRADATION OF THE SECOND MESSENGER NAADP
Grolla A., Travelli C., Polzonetti V., Del Grosso E., Billington R., Canonico P., Genazzani A. (Novara, Plymouth) |
A GENOME-SCALE RNAI SCREEN IDENTIFIES EFFECTORS OF FLT3-ITD IN ACUTE MYELOID LEUKIEMA.
Caldarelli A., Paskow-Rozas M., Mueller J., Koch S., Kittler R., Genazzani A., Canonico P., Ding L., Kasper S., Fisher T., Boehmer F., Buchholz F. (Novara, Dresden, Jena, Magdeburg) |